Study of Anlotinib in Patients With Metastatic Colorectal Cancer（mCRC）(ALTER0703)

Clinical trial NCT02332499 · COMPLETED

Trial details

NCT number: NCT02332499
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer

Start date: 2014-12-01
Primary completion: 2016-08-18
Enrollment: 419

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.